Experienced in WT1-Related Wilms Tumor Syndromes

Dr. Matei P. Socoteanu

Oncology | Hospital Medicine | Hematology Oncology
Texas Oncology
Texas Oncology PA
7848 Gateway Blvd E, 
El Paso, TX 
Accepting New Patients
Offers Telehealth

Experienced in WT1-Related Wilms Tumor Syndromes
Texas Oncology
Texas Oncology PA
7848 Gateway Blvd E, 
El Paso, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Matei Socoteanu is an Oncologist and a Hospital Medicine provider in El Paso, Texas. Dr. Socoteanu is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Lung Cancer, and Paget Disease of the Breast. Dr. Socoteanu is currently accepting new patients.

His clinical research consists of co-authoring 2 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Oncology
Hospital Medicine
Hematology Oncology
Licenses
Internal Medicine in TN
Hospital Affiliations
Christus Good Shepherd Medical Center
Longview Regional Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EMI Health
  • PPO
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Provider Partners Health Plan
  • MEDICARE SNP
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

TEXAS ONCOLOGY PA
7848 Gateway Blvd E, El Paso, TX 79915
Call: 915-599-1313
Other Locations
TEXAS ONCOLOGY PA
815 S Washington Ave, Suite 204, Marshall, TX 75670
Call: 903-935-4601
TEXAS ONCOLOGY PA
1400 N 4th St, Longview, TX 75601
Call: 903-757-2122
TEXAS ONCOLOGY PA
2026 S Jackson St, Jacksonville, TX 75766
Call: 903-586-2456

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


3 Clinical Trials

A Phase 2 Open-label Study of Brentuximab Vedotin in Front-line Therapy of Hodgkin Lymphoma (HL) an dCD30-expressing Peripheral T-cell Lymphoma (PTCL) in Older Patients or Patients With Significant Comorbidities Ineligible for Standard Chemotherapy
A Phase 2 Open-label Study of Brentuximab Vedotin in Front-line Therapy of Hodgkin Lymphoma (HL) an dCD30-expressing Peripheral T-cell Lymphoma (PTCL) in Older Patients or Patients With Significant Comorbidities Ineligible for Standard Chemotherapy
Enrollment Status: Completed
Publish Date: June 11, 2024
Intervention Type: Drug
Study Drugs: Brentuximab, Bendamustine, Dacarbazine, Nivolumab
Study Phase: Phase 2
A Randomized Phase 2 Trial of AM0010 in Combination With Pembrolizumab vs. Pembrolizumab Alone as First-Line (1L) Therapy in Patients With Stage IV / Metastatic Wild Type (WT) Non-Small Cell Lung Cancer and Tumors With High Expression of PD-L1 (> 50%)
A Randomized Phase 2 Trial of AM0010 in Combination With Pembrolizumab vs. Pembrolizumab Alone as First-Line (1L) Therapy in Patients With Stage IV / Metastatic Wild Type (WT) Non-Small Cell Lung Cancer and Tumors With High Expression of PD-L1 (> 50%)
Enrollment Status: Terminated
Publish Date: January 20, 2021
Intervention Type: Drug, Biological
Study Phase: Phase 2
A Randomized Phase 2 Trial of AM0010 in Combination With Nivolumab vs. Nivolumab Alone as Second-Line Therapy in Subjects With Stage IV / Metastatic Wild Type Non-Small Cell Lung Cancer and Low Tumor Expression of PD-L1
A Randomized Phase 2 Trial of AM0010 in Combination With Nivolumab vs. Nivolumab Alone as Second-Line Therapy in Subjects With Stage IV / Metastatic Wild Type Non-Small Cell Lung Cancer and Low Tumor Expression of PD-L1
Enrollment Status: Terminated
Publish Date: September 11, 2020
Intervention Type: Biological, Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

2 Total Publications

Randomized Phase 2 Studies of Checkpoint Inhibitors Alone or in Combination With Pegilodecakin in Patients With Metastatic NSCLC (CYPRESS 1 and CYPRESS 2).
Randomized Phase 2 Studies of Checkpoint Inhibitors Alone or in Combination With Pegilodecakin in Patients With Metastatic NSCLC (CYPRESS 1 and CYPRESS 2).
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: July 10, 2020
View All 2 Publications
Similar Doctors
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Jason L. Smith
Hematology Oncology | Oncology | Hematology
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Jason L. Smith
Hematology Oncology | Oncology | Hematology

Texas Oncology PA

7848 Gateway Blvd E, 
El Paso, TX 
 (0.1 miles away)
915-599-1313
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Jason Smith is a Hematologist Oncology specialist and an Oncologist in El Paso, Texas. Dr. Smith is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Paget Disease of the Breast, and Urothelial Cancer. Dr. Smith is currently accepting new patients.

Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Panagiotis N. Valilis
Hematology Oncology | Oncology
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Panagiotis N. Valilis
Hematology Oncology | Oncology
7848 Gateway Blvd E, 
El Paso, TX 
 (0.1 miles away)
915-599-1313
Languages Spoken:
English, Greek, Mandarin, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Panagiotis Valilis is a Hematologist Oncology specialist and an Oncologist in El Paso, Texas. Dr. Valilis is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Paget Disease of the Breast, Familial Colorectal Cancer, Familial Pancreatic Cancer, and Inflammatory Breast Cancer. Dr. Valilis is currently accepting new patients.

Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Zening H. He
Oncology | Hematology Oncology | Hematology
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Zening H. He
Oncology | Hematology Oncology | Hematology
1900 N Oregon St, Suite 305, 
El Paso, TX 
 (8.7 miles away)
915-225-2027
Languages Spoken:
English, Mandarin, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Zening He is an Oncologist and a Hematologist Oncology provider in El Paso, Texas. Dr. He is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Pleuropulmonary Blastoma, Pulmonary Embolism, Drug-Induced Thrombocytopenia, Thrombocytopenia, and Bone Marrow Aspiration. Dr. He is currently accepting new patients.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Socoteanu's expertise for a condition
ConditionClose
    • Distinguished
    • Acquired Agranulocytosis
      Dr. Socoteanu is
      Distinguished
      . Learn about Acquired Agranulocytosis.
      See more Acquired Agranulocytosis experts
    • Colorectal Cancer
      Dr. Socoteanu is
      Distinguished
      . Learn about Colorectal Cancer.
      See more Colorectal Cancer experts
    • Familial Colorectal Cancer
      Dr. Socoteanu is
      Distinguished
      . Learn about Familial Colorectal Cancer.
      See more Familial Colorectal Cancer experts
    • Lung Cancer
      Dr. Socoteanu is
      Distinguished
      . Learn about Lung Cancer.
      See more Lung Cancer experts
    • Myelodysplastic Syndrome (MDS)
      Dr. Socoteanu is
      Distinguished
      . Learn about Myelodysplastic Syndrome (MDS).
      See more Myelodysplastic Syndrome (MDS) experts
    • Non-Hodgkin Lymphoma
      Dr. Socoteanu is
      Distinguished
      . Learn about Non-Hodgkin Lymphoma.
      See more Non-Hodgkin Lymphoma experts
    View All 8 Distinguished Conditions
    • Advanced
    • Anal Cancer
      Dr. Socoteanu is
      Advanced
      . Learn about Anal Cancer.
      See more Anal Cancer experts
    • B-Cell Lymphoma
      Dr. Socoteanu is
      Advanced
      . Learn about B-Cell Lymphoma.
      See more B-Cell Lymphoma experts
    • Breast Cancer
      Dr. Socoteanu is
      Advanced
      . Learn about Breast Cancer.
      See more Breast Cancer experts
    • Diffuse Large B-Cell Lymphoma (DLBCL)
      Dr. Socoteanu is
      Advanced
      . Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
      See more Diffuse Large B-Cell Lymphoma (DLBCL) experts
    • Familial Prostate Cancer
      Dr. Socoteanu is
      Advanced
      . Learn about Familial Prostate Cancer.
      See more Familial Prostate Cancer experts
    • Follicular Lymphoma
      Dr. Socoteanu is
      Advanced
      . Learn about Follicular Lymphoma.
      See more Follicular Lymphoma experts
    View All 18 Advanced Conditions
    • Experienced
    • Acute Mountain Sickness
      Dr. Socoteanu is
      Experienced
      . Learn about Acute Mountain Sickness.
      See more Acute Mountain Sickness experts
    • Acute Myeloblastic Leukemia with Maturation
      Dr. Socoteanu is
      Experienced
      . Learn about Acute Myeloblastic Leukemia with Maturation.
      See more Acute Myeloblastic Leukemia with Maturation experts
    • Acute Myeloblastic Leukemia without Maturation
      Dr. Socoteanu is
      Experienced
      . Learn about Acute Myeloblastic Leukemia without Maturation.
      See more Acute Myeloblastic Leukemia without Maturation experts
    • Acute Myeloid Leukemia (AML)
      Dr. Socoteanu is
      Experienced
      . Learn about Acute Myeloid Leukemia (AML).
      See more Acute Myeloid Leukemia (AML) experts
    • Adult Soft Tissue Sarcoma
      Dr. Socoteanu is
      Experienced
      . Learn about Adult Soft Tissue Sarcoma.
      See more Adult Soft Tissue Sarcoma experts
    • Agranulocytosis
      Dr. Socoteanu is
      Experienced
      . Learn about Agranulocytosis.
      See more Agranulocytosis experts
    View All 94 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved